Received Sep 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | IM |
Red rash over all body, lighter on arms and legs, not red day later but still pale; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Red rash over all body, lighter on arms and legs, not red day later but still pale) in an 82-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 milliliter. On 24-Sep-2025, after starting mRNA-1273.251 (Spikevax LP.8.1 PFS), the patient experienced RASH (Red rash over all body, lighter on arms and legs, not red day later but still pale). At the time of the report, RASH (Red rash over all body, lighter on arms and legs, not red day later but still pale) was resolving. The concomitant medication was not reported by the reporter. The patient had a red rash all over the body, which was lighter on the arms and legs. A day later, it was not red but still pale. The patient did not have welts or hives. She did not call the doctor as it was resolving. It was unknown if the patient experienced any additional symptoms or events. The treatment medication was not reported by the reporter.